Pfizer Head Gives Insight into Big Pharma Versus Biotech

10 October

In October 2005, veski and the BioMelbourne Network held a CEO luncheon featuring Dr David Alker, the Senior Research Fellow, Head - Discovery Staffing Group, Pfizer Global Research and Development, Sandwich Laboratories in the United Kingdom.

Dr Alker spoke about how technical convergence and innovation partnership models are affecting the big pharma. He also gave the audience the benefit of his observations on how Australian talent moving to the major northern hemisphere markets to further their careers and skill levels, can engage with the big pharmaceutical companies.

What's On

October

S M T W T F S
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31
 
 
 
 
 

What people say about veski

“Our research program is focused on working with industrial partners to develop novel therapeutics that will transform the treatment of chronic inflammatory diseases such as IBD.”

- Professor Colby Zaph

Tweets from @veskiorg